23 July 2020 : Clinical Research
Clinicopathological Analysis and Prognostic Assessment of Transcobalamin I (TCN1) in Patients with Colorectal Tumors
Xinqiang Zhu12ABCDEG*, Kui Yi3BE, Daorong Hou4ADF, Hailong Huang2BC, Xuetong Jiang2ABE, Xiaohong Shi2BCE, Chungen Xing1AEFDOI: 10.12659/MSM.923828
Med Sci Monit 2020; 26:e923828
Table 1 Clinicopathologic data.
Parameters | Number of cases | Percentage |
---|---|---|
Age | ||
<65 years | 78 | 63.4 |
≥65 years | 45 | 36.6 |
Mean±SD | 53.61±2.128 | |
Median | 61 | |
Age range | 39–81 | |
Sex | ||
Female | 57 | 46.3 |
Male | 66 | 53.7 |
CEA level | ||
Increased | 45 | 36.6 |
Normal | 78 | 63.7 |
CA125 level | ||
Increased | 27 | 22.0 |
Normal | 96 | 78.0 |
CA19-9 level | ||
Increased | 24 | 19.5 |
Normal | 99 | 80.5 |
Tumor location | ||
Colon | 30 | 24.4 |
Distal colon | 27 | 22.0 |
Rectum | 66 | 53.6 |
Histological differentiation | ||
G1 | 30 | 24.4 |
G2 | 48 | 39.0 |
G3 | 45 | 36.6 |
Depth of invasion | ||
T1/T2 | 21 | 17.1 |
T3/T4 | 102 | 82.9 |
Tumor size | ||
<5 cm | 66 | 53.7 |
≥5 cm | 57 | 46.3 |
Metastases to regional lymph nodes | ||
No | 66 | 53.7 |
Yes | 57 | 46.3 |
Nerve invasion | ||
No | 75 | 61.0 |
Yes | 48 | 39.0 |
Adjuvant chemotherapy | ||
No | 5 | 4.1 |
Yes | 118 | 95.9 |
CEA – carcinoembryonic antigen; CA125 – cancer antigen 125; CA19-19 – cancer antigen 19-9. |